Ad
Tuesday, 9 July 2019
Novartis launches Adamis allergy shots in U.S. pharmacies amid EpiPen shortage
A unit of Novartis AG said on Tuesday it would make partner Adamis Pharmaceuticals Corp's emergency allergy shots immediately available in local pharmacies across the United States, amid a shortage of Mylan NV's rival product, EpiPen.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment